Precision medicine for COVID-19: a call for better clinical trials
Open Access
- 2 June 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-3
- https://doi.org/10.1186/s13054-020-03002-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Optimizing the Trade-off Between Learning and Doing in a PandemicJAMA, 2020
- Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for actionBritish Journal of Haematology, 2020
- Critical Illness in Patients With COVID-19 Mounting an Effective Clinical and Research ResponseJama-Journal Of The American Medical Association, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- COVID-19 pneumonia: ARDS or not?Critical Care, 2020
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic ReviewCritical Care Medicine, 2019
- Prognostic and predictive enrichment in sepsisNature Reviews Nephrology, 2019
- Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? NoIntensive Care Medicine, 2018